Phase 1 - Linear EGFR-binding peptide

Our initial approach involved designing a linear EGFR-binding peptide (Ebp), CMYIEALDRYAF BioBrick combining the gene encoding the peptide and a His-tag.

1. BioBrick design:

Figure 1 Vector design of pET-24d(+)-Ebp

2. Transformation to TOP10 competent cells

Background:

Recombinant plasmid was transformed to TOP10 competent cells.

Only bacteria received Kanamycin resistant gene in recombinant vector survived in LB agar plate containing kanamycin.

Observation

Multiple colonies were observed.

Conclusion:

Successful transformation of pET-24d(+)-Ebp plasmid to TOP10 cells is confirmed by the presence of transformants on the LB agar plate.

Figure 2 LB agar plate with pET-24d(+)-Ebp transformants (TOP10)

3. Transformation to competent BL21(DE3)

Background

Recombinant plasmid pET-24d(+)-Ebp obtained from TOP10 colonies are purified and transformed to BL21(DE3) cells.

Only bacteria received Kanamycin resistant gene in recombinant vector survived in LB agar plate containing kanamycin.

Observation:

Multiple colonies were observed.

Conclusion:

Successful transformation of pET-24d(+)-Ebp plasmid to BL21 (DE3) cells is confirmed by the presence of transformants on the LB agar plate.

Figure 3 LB agar plate with pET-24d(+)-Ebp transformants [BL21(DE3)]

4. Peptide Expression

Background:

BL21 (DE3) cells carrying the recombinant plasmid pET-24d(+)-Ebp was induced with 0.2 mM IPTG and cultured at 25 °C overnight.

The expressed peptide was extracted by lysis buffer and loaded to Tricine protein gel to check for the expression.

Observation:

The expected size of the peptide is 2.4 kDa. No band was observed in the tricine protein gel.

Conclusion:

Fail to express the linear peptide.

Disappointingly, the expected 2.4 kDa band representing the linear EGFR binding peptide was not present in the protein gel. We reasoned that this might be due to the insolubility resulting from bacterial rupture or peptide degradation or other unknown factors. To solve this problem, we adopted suggestions from advisers that cyclic peptide could be the possible solution. Therefore, we included a cyclic form of CMYIEALDRYAF in our phase 2 BioBrick engineering.

Phase 2 - Ssp-Mxe intein splicing BioBrick

To generate cyclic EGFR peptide in vitro, we designed and built an Ssp-Mxe intein splicing BioBrick. An intein is a segment of a protein that is able to excise itself and join the remaining portions with a peptide bond during protein splicing. The BioBrick was designed to be flanked by two chitin binding domains (CBD), which enables one-step purification and cyclization of the target peptide. We also included a scrambled peptide with random amino acids as a negative control for subsequent conjugation.

1. BioBrick design:

Figure 4 Vector design of pET-24d(+)-Ebp-Ssp-Mxe (ES)
Figure 5Vector design of pET-24d(+)-Scrb-Ssp-Mxe (SS)

2. Sub-cloning of Ebp-Ssp-Mxe and Scrb-Ss-Mxe inserts to pET-24d(+)

The inserts were synthesized by the IDT company and carried by a default pUC cloning vector.

pUC Vectors with desired insert (ES and SS) were digested with XbaI and HindIII. Two fragments with different lengths were expected.

ES & SS insert size: 1539 bp.

pUC plasmid backbone size: 2752 bp.

Observation:

Two or three bands were observed at each lane. All the samples showed a band of ~1500 bp in size.

Conclusion:

Restriction digestion has been successfully performed. The Ebp-Ssp-Mxe and Scrb-Ssp-Mxe inserts are purified and ready for sub-cloning to pET-24d(+) plasmid. The presence of an extra third band in lane 4 is the uncut vector caused by incomplete digestion.

Figure 6DNA gel electrophoresis result of restriction digested vector. Lane 1, Thermo Fisher Scientific GeneRuler 1kb DNA Ladder; lane 2 and 3, restriction digested pUC-Ebp-Ssp-Mxe (ES); lane 4 and 5, pUC-Scrb-Ssp-Mxe (SS).

3. Transformation to TOP10 competent cells

Background:

The inserts (Ebp-Ssp-Mxe and Scrb-Ssp-Mxe) and pET-24d(+) plasmid were digested with XbaI and HindIII and ligated to form recombinant plasmids pET-24d(+)-Ebp-Ssp-Mxe and pET-24d(+)-Scrb-Ssp-Mxe .

Ligation products were transformed to TOP10 competent cells.

Only bacteria received Kanamycin resistant gene in recombinant vector survived in LB agar plate containing kanamycin.

Observation:

Multiple colonies were observed.

Conclusion:

Successful transformation and ligation of pET-24d(+)-Ebp-Ssp-Mxe and pET-24d(+)-Scrb-Ssp-Mxe to TOP10 cells are confirmed by the presence of transformants on the LB agar plate.

Figure 7LB agar plate with pET-24d(+)-Ebp-Ssp-Mxe transformants (TOP10)
Figure 8LB agar plate with pET-24d(+)-Scrb-Ssp-Mxe transformants (TOP10).

4.1 Restriction digestion of recombinant plasmid for colony selection

Background:

Recombinant pET-24d(+)-Ebp-Ssp-Mxe plasmid was cut by XbaI and HindIII to confirm the insert size.

ES insert size: 1539bp.

pET-24d(+) plasmid backbone size: 5207 bp.

Observation:

All the samples showed bands of ~5000 bp and ~1500 bp in size.

Conclusion:

Insert Ebp-Ssp-Mxe has been successfully sub-cloned to the pET-24d(+) plasmid.

Figure 9DNA gel electrophoresis result of restriction digested pET-24d(+)-Ebp-Ssp-Mxe (ES). Lane 1, Thermo Fisher Scientific GeneRuler 1kb DNA Ladder; lane 2 to 6, restriction digested pET-24d(+)-Ebp-Ssp-Mxe (ES) from different colonies.

4.2 Colony PCR of recombinant plasmid for colony selection

Background:

Recombinant plasmid was confirmed by colony PCR using the T7 universal primers. The target band was expected to be 168 bp longer than original insert size.

SS insert size: 1539 bp.

Amplicon size: 1707 bp.

Observation:

All the samples showed bands of ~1700 bp in size.

Conclusion:

Insert Scrb-Ssp-Mxe has been successfully sub-cloned to the pET-24d(+) plasmid.

Figure 10DNA gel electrophoresis result of colony PCR of pET-24d(+)-Scrb-Ssp-Mxe (SS). Lane 1, Thermo Fisher Scientific GeneRuler 1kb DNA Ladder; lane 2 to 9, PCR products of Scrb-Ssp-Mxe (SS) from different colonies.

5. Transformation to BL21(DE3)

Background:

pET-24d(+)-Ebp-Ssp-Mxe and pET-24d(+)-Scrb-Ssp-Mxe were purified and transformed to BL21(DE3).

Only bacteria received Kanamycin resistant gene in recombinant vector survived in LB agar plate containing kanamycin.

Observation:

Multiple colonies were observed.

Conclusion:

Successful transformation of pET-24d(+)-Ebp-Ssp-Mxe and pET-24d(+)-Scrb-Ssp-Mxe plasmids to BL21(DE3) cells is confirmed by the presence of transformed colonies on the LB agar plate.

Figure 11LB agar plate with pET-24d(+)-Ebp-Ssp-Mxe transformants [BL21(DE3)].
Figure 12 LB agar plate with pET-24d(+)-Scrb-Ssp-Mxe transformants [BL21(DE3)].

6. Sequencing result

Background:

Colonies were selected from the LB agar plate and sent for DNA sequencing.

Observation:

No mutation was found in the peptide coding sequence of the selected plasmids.

Conclusion:

The DNA sequencing result confirmed the recombinant plasmid has no mutation. The recombinant plasmid, pET-24d(+)-Ebp-Ssp-Mxe and pET-24d(+)-Scrb-Ssp-Mxe are ready for expression.

7. Expression

Background:

After 0.2 mM of IPTG induction, cells were cultured at 25℃ overnight. Cells were harvested and lysed through sonication.

After centrifugation, supernatant and pellet were obtained and indicated as soluble and insoluble groups, respectively.

Soluble and insoluble samples were mixed with 6X SDS loading buffer, and denatured by heating at 90℃ for 5 mins.

Samples were loaded to SDS-PAGE Gel and run for 60 min at 120 V.

Expected molecular weight (MW) of Ebp-Ssp-Mxe: 54.5 kDa & Scrb-Ssp-Mxe: 54.6 kDa.

Observation:

Compared to the uninduced sample, the induced sample clearly showed an extra band with high intensity, in both soluble and insoluble fractions. The target protein is indicated by the red bracket (~50 kDa).

Conclusion:

The distinct bands present in the IPTG induced samples indicates successful expression of target protein. The distinct band at ~ 50 kDa matches the expected MW of Ebp-Ssp-Mxe protein and Scrb-Ssp-Mxe protein.

Figure 13 TGX stain free gel showing protein expression of Ebp-Ssp-Mxe (ES). Lane 1, Biorad Precision Plus Protein™ Unstained Protein Standards; lane 2, IPTG induced soluble fraction; lane 3, IPTG induced insoluble fraction; lane 4, uninduced soluble fraction; lane 5, uninduced insoluble fraction. Sol = soluble; Insol = insoluble
Figure 14 TGX stain free gel showing protein expression of Scrb-Ssp-Mxe (SS). Lane 1, Biorad Precision Plus Protein™ Unstained Protein Standards; lane 2, IPTG induced soluble fraction; lane 3, IPTG induced insoluble fraction; lane 4, uninduced soluble fraction; lane 5, uninduced insoluble fraction. Sol = soluble; Insol = insoluble.

We then proceeded to the purification. The protein lysate containing the intein splicing BioBrick was loaded to the chitin column for one-step purification and cyclization. Unexpectedly, the desired cyclic peptide was not detected by LC-ESI-MS analysis. One possible cause of this outcome could be because the Ssp-Mxe intein system might not be capable of generating short cyclic peptides. In response to this, we employed another intein called Npu intein, which has been reported as an effective intein for short peptide cyclization.

Phase 3 - Npu intein splicing BioBrick

In phase 3, we substituted the original Ssp-Mxe intein with the Npu intein, which is specialized for generating short cyclic peptides. This phase involved three BioBricks: the target and scrambled peptide, and a eGFP positive control. Similar to the Ssp-Mxe intein system, the BioBrick was flanked by two chitin binding domain.

1. BioBrick design:

Figure 15Vector design of pET-24d(+)-Ebp-Npu-SsrA (EN).
Figure 16Vector design of pET-24d(+)-Scrb-Npu-SsrA (SN).
Figure 17Vector design of pET-24d(+)-GFP-Npu-SsrA (GN).

2. Sub-cloning of Ebp-Npu-SsrA (EN), Scrb-Npu-SsrA (SN) and eGFP-Npu-SsrA (GN) inserts to pET-24d(+)

Background:

The inserts were synthesized by the IDT company and carried by a default pUC cloning vector.

pUC vectors with desired insert (EN, SN and GN) were digested with XbaI and HindIII. Two fragments with different lengths were expected.

EN & SN insert size: 972 bp.

GN insert size: 1653 bp.

pUC plasmid backbone size: 2752 bp.

Observation:

Two or three bands were observed at each lane. Sample 2 to 5 showed a band of ~900 bp in size. Sample 6 and 7 showed a band of ~1600 bp in size. All samples showed a band of ~2500 bp in size.

Conclusion:

Restriction digestion has been successfully performed. The Ebp-Npu-SsrA, Scrb-Npu-SsrA and eGFP-Npu-SsrA inserts are purified and ready for sub-cloning to pET-24d(+) plasmid. The presence of an extra third band in lane 3 and 6 are the uncut vector caused by incomplete digestion.

Figure 18DNA gel electrophoresis result of restriction digested vector. Lane 1, Thermo Fisher Scientific GeneRuler 1kb DNA Ladder; lane 2 and 3, restriction digested pUC-Ebp-Npu-SsrA (EN); lane 4 and 5, pUC-Scrb-Npu-SsrA (SN); lane 6 and 7, pUC-GFP-Npu-SsrA (GN).

3. Transformation to TOP10

Background:

The inserts (Ebp-Npu-SsrA, Scrb-Npu-SsrA and eGFP-Npu-SsrA) and pET-24d(+) plasmid were digested with XbaI and HindIII and ligated to form recombinant plasmids pET-24d(+)-Ebp-Npu-SsrA, pET-24d(+)-Scrb-Npu-SsrA and pET-24d(+)-eGFP-Npu-SsrA.

Ligation products were transformed to TOP10 competent cells.

Only bacteria received Kanamycin resistant gene in recombinant vector survived in LB agar plate containing kanamycin.

Observation:

Multiple colonies were observed

Conclusion:

Successful transformation and ligation of pET-24d(+)-Ebp-Npu-SsrA, pET-24d(+)-Scrb-Npu-SsrA and pET-24d(+)-eGFP-Npu-SsrA to TOP10 cells are confirmed by the presence of transformants on the LB agar plate.

Figure 19LB agar plate with pET-24d(+)-Ebp-Npu-SsrA transformants (TOP10).
Figure 20 LB agar plate with pET-24d(+)-Scrb-Npu-SsrA transformants (TOP10)
Figure 21 LB agar plate with pET-24d(+)-GFP-Npu-SsrA transformants (TOP10).

4.1 Restriction digestion of recombinant plasmid for colony selection

Background:

Recombinant pET-24d(+)-Ebp-Npu-SsrA plasmid was cut by XbaI and HindIII to confirm the insert size.

ES insert size: 978 bp.

pET-24d(+) plasmid backbone size: 5207 bp.

Observation:

All the samples showed bands of ~5000 bp and ~900 bp in size.

Conclusion:

Insert Ebp-Npu-SsrA has been successfully sub-cloned to the pET-24d(+) plasmid.

Figure 22DNA gel electrophoresis result of restriction digested pET-24d(+)-Ebp-Npu-SsrA (EN). Lane 1, Thermo Fisher Scientific GeneRuler 1kb DNA Ladder; lane 2 to 6, restriction digested pET-24d(+)-Ebp-Npu-SsrA (EN) from different colonies.

4.2 Colony PCR of recombinant plasmid for colony selection

Background:

Recombinant plasmid was confirmed by colony PCR using the T7 universal primers. The target band was expected to be 168 bp longer than original insert size.

SS insert size: 978 bp.

Amplicon size: 1146 bp.

Observation:

All the samples showed bands of ~1100 bp in size.

Concluding remarks:

Insert Scrb-Npu-SsrA has been successfully sub-cloned to the pET-24d(+) plasmid.

Figure 23DNA gel electrophoresis result of colony PCR of pET-24d(+)-Scrb-Npu-SsrA (SN). Lane 1, Thermo Fisher Scientific GeneRuler 1kb DNA Ladder; lane 2 to 8, PCR products of Scrb-Npu-SsrA (SN) from different colonies.

Background:

Recombinant plasmid was confirmed by colony PCR using the T7 universal primers. The target band was expected to be 168 bp longer than original insert size.

GN insert size: 1659 bp.

Amplicon size: 1827 bp.

Observation:

All the samples showed bands of ~1800 bp in size

Conclusion:

Insert eGFP-Npu-SsrA has been successfully sub-cloned to the pET-24d(+) plasmid.

Figure 24DNA gel electrophoresis result of colony PCR of pET-24d(+)-GFP-Npu-SsrA (GN). Lane 1, Thermo Fisher Scientific GeneRuler 1kb DNA Ladder; lane 2 to 9, PCR products of GFP-Npu-SsrA (GN) from different colonies.

5 Transformation to BL21(DE3)

Background:

pET-24d(+)-Ebp-Npu-SsrA, pET-24d(+)-Scrb-Npu-SsrA and pET-24d(+)-eGFP-Npu-SsrA were purified and transformed to BL21(DE3).

Only bacteria received Kanamycin resistant gene in recombinant vector survived in LB agar plate containing kanamycin.

Observation:

Multiple colonies were observed.

Conclusion:

Successful transformation of pET-24d(+)-Ebp-Npu-SsrA, pET-24d(+)-Scrb-Npu-SsrA and pET-24d(+)-eGFP-Npu-SsrA plasmids to BL21(DE3) cells is confirmed by the presence of transformed colonies on the LB agar plate.

Figure 25LB agar plate with pET-24d(+)-Ebp-Npu-SsrA transformants [BL21(DE3)].
Figure 26LB agar plate with pET-24d(+)-Scrb-Npu-SsrA transformants [BL21(DE3)].
Figure 27LB agar plate with pET-24d(+)-GFP-Npu-SsrA transformants [BL21(DE3)].

6 Sequencing result

Background:

Colonies were selected from the LB agar plate and sent for DNA sequencing.

Observation:

No mutation was found in the peptide coding sequence of the selected plasmids.

Conclusion:

The DNA sequencing result confirmed the recombinant plasmid has no mutation. The recombinant plasmid, pET-24d(+)-Ebp-Npu-SsrA, pET-24d(+)-Scrb-Npu-SsrA and pET-24d(+)-eGFP-Npu-SsrA plasmids are ready for expression.

7 Expression

Background:

After 0.2 mM of IPTG induction, cells were cultured at 25℃ overnight. Cells were harvested and lysed through sonication.

After centrifugation, supernatant and pellet were obtained and indicated as soluble and insoluble groups, respectively.

Denatured sample were mixed with 6X SDS loading buffer and denatured by heating at 90℃ for 5 mins.

Native samples were mixed with 6X native gel loading buffer and were not denatured by heating.

Samples were loaded to SDS-PAGE Gel and run for 60 min at 120 V.

Expected molecular weight (MW) of Ebp-Npu-SsrA : 34.6 kDa

Observation:

Compared to the uninduced samples, the induced samples clearly showed an extra band with high intensity in soluble fraction. The target protein is indicated by the red bracket (denatured samples: ~21 kDa; native sample: ~34 kDa).

Conclusion:

The distinct bands present in the IPTG-induced samples indicate successful expression of the target protein. The distinct band at ~34 kDa in the native gel matches the expected molecular weight (MW) of the Ebp-Npu-SsrA protein. The band at ~20 kDa in the denatured sample is assumed to be a fragment of the Ebp-Npu-SsrA protein due to premature intracellular cleavage of part of the intein from the target protein. The MW of the cleaved intein is around ~14 kDa. However, it cannot be seen in the gel photo due to sample overflow, which is indicated by the disappearance of the 15 kDa band in the MW ladder.

Figure 28TGX stain free gel showing protein expression of Ebp-Npu-SsrA (EN). Lane 1 and 6, Biorad Precision Plus Protein™ Unstained Protein Standards; lane 2 and 7, IPTG induced soluble fractions; lane 3 and 8, IPTG induced insoluble fractions; lane 4 and 9, uninduced soluble fractions; lane 5 and 10, uninduced insoluble fractions. Lane 2 to 5 are denatured samples while lane 7 to 10 are native samples. Sol = soluble; Insol = insoluble.

Background:

After 0.2 mM of IPTG induction, cells were cultured at 25℃ overnight. Cells were harvested and lysed through sonication.

After centrifugation, supernatant and pellet were obtained and indicated as soluble and insoluble groups, respectively.

Denatured samples were mixed with 6X SDS loading buffer and denatured by heating at 90℃ for 5 mins.

Native samples were mixed with 6X native gel loading buffer and were not denatured by heating.

Samples were loaded to SDS-PAGE Gel and run for 60 min at 120 V.

Expected molecular weight (MW) of Scrb-Npu-SsrA : 34.6 kDa.

Observation:

Compared to the uninduced samples, the induced samples clearly showed an extra band with high intensity in soluble fraction. The target protein is indicated by the red bracket (denatured samples: ~21 kDa and ~15 kDa; native sample: ~34 kDa).

The distinct bands present in the IPTG induced samples indicate successful expression of target protein. The distinct band at ~ 34 kDa in native gel matches the expected MW of Scrb-Npu-SsrA protein. The bands at ~21 kDa and ~14 kDa in denatured sample are fragments of Scrb-Npu-SsrA protein due to a pre-mature intra-cellular cleavage of part of the intein from the target protein.

Figure 29TGX stain free gel showing protein expression of Scrb-Npu-SsrA (SN). Lane 1 and 6, Biorad Precision Plus Protein™ Unstained Protein Standards; lane 2 and 7, IPTG induced soluble fractions; lane 3 and 8, IPTG induced insoluble fractions; lane 4 and 9, uninduced soluble fractions; lane 5 and 10, uninduced insoluble fractions. Lane 2 to 5 are denatured samples while lane 7 to 10 are native samples. Sol = soluble; Insol = insoluble.

Background:

After 0.2 mM of IPTG induction, cells were cultured at 25℃ overnight. Cells were harvested and lysed through sonication.

After centrifugation, both supernatant and pellet were obtained and indicated as soluble and insoluble groups, respectively.

Samples were mixed with 6X native gel loading buffer and were not denatured by heating.

Samples were loaded to SDS-PAGE Gel and run for 60 min at 120 V.

Expected molecular weight (MW) of eGFP-NPU-SsrA : 60 kDa.

Observation:

The IPTG-induced samples clearly showed distinct band(s) in soluble fraction. The target protein is indicated by the red bracket (~60 kDa).

Conclusion:

The distinct bands present in the IPTG induced samples indicates successful expression of target protein. The distinct band at ~ 60 kDa matches the expected MW of eGFP-Npu-SsrA protein.

Figure 30TGX stain free native gel showing protein expression of GFP-Npu-SsrA (GN). Lane 1 , Biorad Precision Plus Protein™ Unstained Protein Standards; lane 2, IPTG induced soluble fraction; lane 3, IPTG induced insoluble fraction; lane 4, uninduced soluble fraction; lane 5, uninduced insoluble fraction. Sol = soluble; Insol = insoluble.

Observation:

Strong fluorescence was observed in the eGFP-Npu-SsrA induced soluble group.

Conclusion:

eGFP is successfully expressed and the BioBrick is functional.

Figure 31GFP fluorescence of GFP-Npu-SsrA

8 Liquid Chromatography-Electrospray Ionization-Mass Spectrometry (LC-ESI-MS)

Background:

After chitin column purification, the elution fraction was subjected to LC-ESI-MS to determine the presence of the targeted eGFP protein.

The calculated molecular mass of cyclic eGFP was 18 Da less than that of linear eGFP (26941 Da), resulting in a mass of 26923 Da.

Observation:

A peak at 26921 Da was observed.

Conclusion:

Cyclic eGFP was detected in the elution fraction, indicating the successful purification using the chitin column and confirming that the eGFP has been modified into its cyclic form..

Figure 32LC-ESI-MS spectrum of elution fraction after chitin column purification showing the molecular mass of a cyclic GFP (26921 Da).

Owing to the time constraint, the purification and analysis of target peptide could not be finished within the competition period. Yet, the successful cyclization of eGFP control demonstrated that the Npu intein BioBrick is effective for cyclization of our target eGFP-binding peptide.

Functional Assays on Polyneerab

As for proof-of-concept purposes, we used chemically synthesized cyclic peptide for antibody conjugation done in a salty PBS buffer at room temperature and subject to functional assays, such as MTT cytotoxicity assay and enzyme-linked immunosorbent assay (ELISA).

1. Conjugation of chemically synthesized Cyclic Peptide to antibody

Background:

By using bifunctional linker to cyclize and conjugate cyclic EGFR-targeting peptides via phthalaldehyde-amine capture reaction onto anti-c-MET monoclonal antibody to generate the c-MET x EGFR peptidic bispecific antibody, Polyneerab.

Observation:

After the conjugation, SDS-PAGE was used to detect the increased molecular weight of the heavy and light chain of the antibody. Different molar ratios of peptide to antibody were investigated. The data showed that 1:20 gave the best results, while 1:50 led to protein precipitation.

Conclusion:

With such bifunctional linker design, cyclic peptides were successfully conjugated to the antibody to generate a novel bispecific antibody.

Figure 33 A) Scheme of one-pot peptide cyclization and antibody modification and B) SDS-PAGE of the cyclic peptide conjugation using the different amounts of cyclic peptides.

2. Binding assay of Polyneerab against c-MET and EGFR by ELISA

Background:

Polyneerab, i.e. anti-c-MET mAb conjugated with cyclic EGFR peptide was tested for its binding affinity towards c-MET and EGFR antigens using ELISA.

A dose response relationship can be found if binding occurs under various concentrations (nM, w/v) of Polyneerab.

Observation:

The EC50 for Polyneerab binding to c-MET and EGFR were 0.17 nM and 32.03 nM respectively.

Conclusion:

Polyneerab binds to both c-MET and EGFR.

Figure 34 ELISA binding assay of Polyneerab against (A) c-MET and (B) EGFR.

3. MTT cytotoxicity confirming Osimertinib resistance of HCC827 human lung cancer cells

Background:

Two HCC827 human lung cancer cell lines (Mock and Osimertinib resistant) were compared for the Osimertinib resistance.

Osimertinib resistant HCC827 cells are expected to demonstrate a higher IC50 compared to mock HCC827 cells.

Observation:

The IC50 for HCC827 Mock and Osimertinib resistant groups towards Osimertinib were 9.930 nM and 2.574 µM respectively.

HCC827 Osimertinib resistant group is 270-fold more resistant than its mock group towards Osimertinib.

Conclusion:

Osimertinib resistant HCC827 cells demonstrate the acquired Osimertinib resistance.

Figure 35MTT assay of HCC827 cell lines (Mock and Osimertinib resistant). Dose response curve showing the cell viability under different Osimertinib concentrations over 72 h.

4. Synergistic effect of Polyneerab and Osimertinib on overcoming Osimertinib-resistance in HCC827 cells.

Background:

Osimertinib resistant HCC827 cells were used to study the reversal activities of Osimertinib resistance by Polyneerab.

Co-treatment with Osimertinib and Polyneerab was expected to demonstrate a synergistic effect and reverse Osimertinib resistance.

Observation:

Polyneerab exerted a maximal synergistic growth suppressive effect in combination with Osimertinib in Osimertinib resistant HCC827 cells.

Growth-suppressive effect of Polyneerab was much more profound when compared to c-MET antibody alone.

Conclusion:

Polyneerab demonstrates a synergistic effect in reversing the drug resistance of Osimertinib resistant HCC827 cells to Osimertinib. Targeting both c-MET and EGFR by Polyneerab yields the best therapeutic efficacy.

Figure 36Combined treatment of Polyneerab with Osimertinib synergistically inhibited the growth of Osimertinib resistant HCC827 cells. Cells were treated with the indicated combination at different doses for 48 hrs. Cell viability was measured using MTT assay. Positive value in excess over Bliss indicated a synergistic effect in the combined treatment.

With the success of the ELISA showing the specific binding of Polyneerab to EGFR and c-MET antigens, we proceeded to examine its effect in sensitizing the resistant HCC827 cells to Osimertinib by MTT assay. Bliss analysis revealed that our Polyneerab exerted a maximal synergistic growth suppressive effect in combination with Osimertinib. Strikingly, such growth-suppressive effects were more profound when compared to anti-c-MET antibody alone, indicating the robustness of targeting both c-MET and EGFR simultaneously using our novel bispecific antibody, Polyneerab. Based on this encouraging preliminary data, Polyneerab is a promising agent to overcome Osimertinib-resistance in NSCLC.